Radioresistance in murine solid tumors induced by interleukin-1

Radiation Research

Volumn 145, Issue 2, 1996, Pages 150-156

  Braunschweiger, Paul G ^a   Basrur, Vathsala ^a   Santos, Octavio ^a   Adessa, Anthony ^a   Houdek, Pavel ^a   Markoe, Arnold M ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; INTERLEUKIN 1ALPHA; SUPEROXIDE DISMUTASE; TIRAPAZAMINE;

ANIMAL CELL; ARTICLE; CELL HYPOXIA; CELL KILLING; CONTROLLED STUDY; HUMAN; MACROPHAGE; MOUSE; PRIORITY JOURNAL; RADIATION PROTECTION; RADIOSENSITIVITY; SOLID TUMOR; TUMOR CELL CULTURE;

ANIMALS; ANOXIA; CATALASE; CELL SURVIVAL; CLONE CELLS; DRUG SYNERGISM; INTERLEUKIN-1; MICE; NEOPLASMS, EXPERIMENTAL; RADIATION INJURIES, EXPERIMENTAL; RADIATION-PROTECTIVE AGENTS; RADIATION-SENSITIZING AGENTS; RECOMBINANT PROTEINS; SUPEROXIDE DISMUTASE; TRIAZINES; TUMOR CELLS, CULTURED; WHOLE-BODY IRRADIATION;

EID: 0030046716     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3579169     Document Type: Article

References (32)

1. M. Partridge, D. Chantry, M. Turner and M. Feldmann. Production of interleukin-1 and interleukin-6 by human keratinocytes and squamous cell carcinoma cells. J. Invest. Dermatol. 96, 771-776 (1991).
2. H. Isihara, K. Tsuneoka, A. B. Dimhev and M. Shikita, Induction and expression of the interleukin-1α gene in mouse spleen by ionizing radiation. Radiat. Res. 133, 321-326 (1993).
3. R. Neta, S. N. Vogel, J. M. Plocinski, N. S. Tare, W. Benjamin, R. Chizzonite and M. Pilcher, In vivo modulation with anti-interleukin-1 (IL-1) receptor (p80) antibody 35F5 of the response to IL-1. The relationship of radioprotection, colony-stimulating factor, and IL-6. Blood 76, 57-62 (1990).
4. M. J. Dorie, A. C. Allison, M. S. Zaghloul and R. F. Kallman, Interleukin 1 protects against the lethal effects of irradiation of mice but has no effect on tumors in the same animals. Proc. Soc. Exp. Biol Med. 119, 23-29 (1989).
5. M. J. Dorie, G. Bedarida and R. F. Kallman, Protection by interleukin-1 against lung toxicity caused by cyclophosphamide and irradiation. Radiat. Res. 128, 316-319 (1991).
6. M. S. Zaghloul, M. J. Dorie and R. F. Kallman. Interleukin-1 modulatory effect on the action of chemotherapeutic drugs and local irradiation of the lip, duodenum and tumor. Int. J. Radiat. Oncol. Biol. Phys. 26, 417-425 (1993).
7. P. Braunschweiger, C. S. Johnson, N. Kumar, V. Ord and P. Furmanski, Antitumor effects of recombinant human interleukin 1α in RIF-1 and PancO2 solid tumors. Cancer Res. 48, 6011-6016 (1988).
8. 31P-Nuclear magnetic resonance studies of the effect of recombinant human interleukin 1α on the bioenergetics of RIF-1 tumors. Cancer Res. 49, 6379-6382 (1989).
9. P. G. Braunschweiger, N. Kumar, I. Constantinidis, J. P. Wehrle, C. S. Johnson and P. Furmanski, Potentiation of interleukin-1α antitumor activity with ketoconazole. Cancer Res. 50, 4709-4717 (1990).
10. P. G. Braunschweiger, N. Kumar, I. Constantinidis, J. P. Wehrle, J. D. Glickson, C. S. Johnson and P. Furmanski, Potentiation of interleukin 1α mediated antitumor effects by ketoconazole. Cancer Res. 50, 4709-4717 (1990).
11. P. G. Braunschweiger, A. S. Jones, S. C. Johnson and P. Furmanski, Potentiation of mitomycin C and porfiromycin antitumor activity in solid tumor models by recombinant human interleukin 1α. Cancer Res. 51, 5454-5460 (1991).
12. P. G. Braunschweiger, V. S. Basrur, O. Santos, A. M. Markoe, P. V. Houdek and J. G. Schwade, Synergistic antitumor activity of cisplatin and interleukin-1 in sensitive and resistant solid tumors. Cancer Res. 53, 1091-1097 (1993).
13. J. H. Zar, Biostatistical Analysis. Prentice-Hall, Englewood Cliffs, NJ, 1974.
14. J. F. Fowler. The linear quadratic formula and progress in fractionated radiotherapy. Br. J. Radiol. 62, 679-694 (1989).
15. T-C. Chou and P. Talalay. Applications of the median effect principle for the assessment of low dose risk of carcinogens and for the quantitation of synergism and antagonism of chemotherapeutic agents. In New Avenues in Developmental Cancer Chemotherapy (K. R. Harrap and T. A. Conners, Eds.), Vol. 1, pp. 37-63. Academic Press, New York, 1987.
16. E. M. Zeman, J. M. Brown, M. J. Lemmon, V. K. Hirst and W. W. Lee, SR-4233: A new bioreductive agent with high selective toxicity for hypoxic mammalian cells. Int. J. Radiat. Oncol. Biol. Phys. 12, 1239-1242 (1986).
17. P. G. Braunschweiger, V. S. Basrur and O. Santos, Interleukin-1α induced oxidants increase cisplatin cytotoxicity in squamous cell carcinoma cells in vitro. Proc. Am. Assoc. Cancer Res. 4, 466 (1993). [Abstract]
18. S. Sen Gupta and S. B. Bhattacharjee, Induction of repair functions by hydrogen peroxide in Chinese hamster cells. Int. J. Radiat. Biol. 53, 935-942 (1988).
19. J. D. Luethy, J. Fargnoli, J. S. Park, A. J. Fornace and N. J. Holbrook, Isolation and characterization of the hamster gadd153 gene. Activation of promoter activity by agents that damage DNA. J. Biol. Chem. 265, 16521-16526 (1990).
20. M. L. Brawn, W. J. Chiou and K. L. Leach, Oxidant-induced activation of protein kinase C in UC11MG cells. Free Radical Res. 22, 23-37 (1995).
21. A. Haimovitz-Friedman, N. Balaban, M. McLoughlin, D. Ehleiter, J. Michaeli, I. Vlodavsky and Z. Fuks, Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res. 54, 2591-2597 (1994).
22. D. E. Hallahan, S. Virudachalam, J. L. Schwartz, N. Panje, R. Mustafi and R. R. Weichselbaum, Inhibition of protein kinases sensitizes human tumor cells to ionizing radiation. Radiat. Res. 129, 345-350 (1992).
23. M. S. Zaghloul, M. J. Dorie and R. F. Kallman, Interleukin-1 increases thymidine labelling index of normal tissues of mice but not the tumor. Int. J. Radiat. Oncol. Biol. Phys. 29, 805-811 (1994).
24. J. M. Brown, W. C. White, L. S. Terada, M. A. Grosso, P. L. Shanley, D. W. Mulvin, A. Banerjee. G. J. R. Whitman and A. H. Harken, Interleukin 1 pretreatment decreases ischemia/reperfusion injury. Cell Biol. 87, 5026-5030 (1990).
25. W. Sumoski, H. Baquerizo and A. Rabinovitch, Oxygen free radical scavengers protect rat islet cells from damage by cytokines. Diabetologia 32, 792-796 (1989).
26. C. W. Song, J-C. Lin and J. C. Lyons, Antitumor effect of interleukin-1 in combination with hyperthermia. Cancer Res. 53, 324-328 (1993).
27. N. Watanabe, Y. Niitsu, H. Umeno, H. Kuriyama, H. Neda, N. Yamauchi, M. Maeda and I. Urushizaki. Toxic effect of tumor necrosis factor on tumor vasculature in mice. Cancer Res. 48, 2179-2183 (1988).
28. H. S. Edwards, J. C. M. Bremmer and I. J. Stratford, Induction of hypoxia in the KHT tumor by tumor necrosis factor and flavone acetic acid. Int. J. Radiat. Biol. 59, 419-432 (1991).
29. M. S. Zaghloul, M. J. Dorie and R. F. Kallman, Interleukin-1 modulatory effects on the actions of chemotherapeutic drugs and localized radiation of the lip, duodenum and tumor. Int. J. Radiat. Oncol. Biol. Phys. 26, 417-425 (1993).
30. S. L. Hancock, R. T. Chung, R. S. Cox and R. F. Kallman. Interleukin-1β initially sensitizes and subsequently protects murine intestinal stem cells exposed to photon radiation. Cancer Res 51, 2280-2285 (1991).
31. D. B. Roberts, E. L. Travis and S. L. Tucker, Interleukin-1 dose, mouse strain, and end point as they affect protection of mouse jejunum. Radiat. Res. 135, 56-63 (1993).
32. P. G. Braunschweiger, S. A. Jones, C. S. Johnson and P. Furmanski, Interleukin-1 induced tumor pathophysiologies can be exploited with bioreductive alkylating agents. Int. J. Radiat. Biol. 60, 369-372 (1991).